Covariate selection and adjustment for efficacy and safety endpoints in indirect comparative effectiveness analyses of CAR-T-cell therapies for large B-cell lymphoma: a systematic review

Marie A-C Neumann, Jonas Jost, Sybille Riou, Stefanie Rungaldier, Stefan Walzer, Jörg Mahlich

Open source

DOI
10.57264/cer-2026-0033
Published
2026-07
Container
Journal of Comparative Effectiveness Research
Publisher
Becaris Publishing Limited
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.57264/cer-2026-0033,
  title = {Covariate selection and adjustment for efficacy and safety endpoints in indirect comparative effectiveness analyses of CAR-T-cell therapies for large B-cell lymphoma: a systematic review},
  author = {Marie A-C Neumann and Jonas Jost and Sybille Riou and Stefanie Rungaldier and Stefan Walzer and Jörg Mahlich},
  year = {2026},
  journal = {Journal of Comparative Effectiveness Research},
  doi = {10.57264/cer-2026-0033},
  url = {https://doi.org/10.57264/cer-2026-0033}
}

RIS

TY  - JOUR
TI  - Covariate selection and adjustment for efficacy and safety endpoints in indirect comparative effectiveness analyses of CAR-T-cell therapies for large B-cell lymphoma: a systematic review
AU  - Marie A-C Neumann
AU  - Jonas Jost
AU  - Sybille Riou
AU  - Stefanie Rungaldier
AU  - Stefan Walzer
AU  - Jörg Mahlich
PY  - 2026
JO  - Journal of Comparative Effectiveness Research
DO  - 10.57264/cer-2026-0033
UR  - https://doi.org/10.57264/cer-2026-0033
ER  - 

APA

Neumann, M. A., Jost, J., Riou, S., Rungaldier, S., Walzer, S., & Mahlich, J. (2026). Covariate selection and adjustment for efficacy and safety endpoints in indirect comparative effectiveness analyses of CAR-T-cell therapies for large B-cell lymphoma: a systematic review. Journal of Comparative Effectiveness Research. https://doi.org/10.57264/cer-2026-0033

Source records